TY - JOUR T1 - 93 Evaluation of perioperative management of advanced ovarian (tubal/peritoneal) cancer patients. A survey from MITO-ManGO Groups JF - International Journal of Gynecologic Cancer JO - Int J Gynecol Cancer SP - A197 LP - A198 DO - 10.1136/ijgc-2021-ESGO.338 VL - 31 IS - Suppl 3 AU - S Greggi AU - F Bifulco AU - A Ferrero AU - P Zola AU - E Busato AU - N Biglia AU - M Stefanetti AU - S Danese AU - G Valabrega AU - F Falcone Y1 - 2021/10/01 UR - http://ijgc.bmj.com/content/31/Suppl_3/A197.abstract N2 - Introduction/Background*Enhanced Recovery After Surgery (ERAS) is currently considered as a global surgical quality improvement initiative. There is a paucity of data, however, concerning its application in advanced ovarian cancer (AOC) patients. The present analysis shows the results of a survey aimed at gathering detailed information on current perioperative management of AOC patients within MITO-ManGO Groups.Methodology A 60-item questionnaire, covering the ERAS items for perioperative care in cytoreductive surgery, was sent to the responsible for each MITO/ManGO centre. Only questionnaires from centres reporting to operate >20 AOC per year were considered for the present analysis.Result(s)*Thirty/30 (100%) questionnaires from eligible centres were analysed. Survey main outcomes were presented and compared with the recommendations from the ERAS Society in table 1. Figure 1 graphically shows concordance between centres’ current behaviour and ERAS recommendations, expressed by rate of concordance. In particular, ≥70% concordance (rate of centres behaving in agreement with ERAS recommendations) was observed in 2/10, 8/12, and 5/9 items, respectively for the pre, intra and postoperative phase.Abstract 93 Figure 1 Concordance between centres‘ behaviour and ERAS recommendations, expressed by rate of centres behaving in agreement with ERAS recommendations (agreement green; disagreement : red)View this table:Abstract 93 Table 1 Survey outcomes compared with the recommendations from the ERAS societyConclusion*Although the recent attempts by the health providers to improve the management of AOC patients, this survey shows that further efforts should be made in order to optimize the perioperative pathway. This is true even in selected centres belonging to national oncological networks. There is a need for a structured peri-operative program specifically targeting AOC patients candidate to cytoreductive surgery. ER -